As filed with the Securities and Exchange Commission on May 15, 2006.
Registration No. 33-65177
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT TO FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
94-2754624
(I.R.S. Employer Identification No.)
4560 Horton Street
Emeryville, CA 94608
(510) 655-8730
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
VIAGENE, INC. EMPLOYEE STOCK PURCHASE PLAN
(Full Title of Plan)
Thomas Kendris, Esq.
Vice President, General Counsel and Secretary
Novartis Vaccines and Diagnostics, Inc.
4560 Horton Street
Emeryville, CA 94608
(510) 655-8730
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
TERMINATION OF REGISTRATION
This Post-Effective Amendment No. 1 relates to the Registration
Statement on Form S-8 (File No. 33-65177) filed on December 20, 1995,
pertaining to the Common Stock of the Registrant, formerly known as Chiron
Corporation, to be offered under the Viagene, Inc. Employee Stock Purchase
Plan.
The undersigned Registrant hereby removes and withdraws from
registration all securities registered pursuant to this Registration
Statement that remain unissued.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this
Post-Effective Amendment to the registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Emeryville,
County of Alameda, State of California on May 15, 2006.
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
By: /s/ Thomas Kendris
-----------------------------------------
Name: Thomas Kendris
Title: Vice President and Secretary
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment to the registration statement has been signed by the
following persons in the capacities and on the dates indicated:
By: /s/ Joerg Reinhardt
-----------------------------------------
Name: Joerg Reinhardt
Title: Director, President and Chief
Executive Officer (Principal
Executive Officer)
Date: May 15, 2006
By: /s/ Reto Braendli
-----------------------------------------
Name: Reto Braendli
Title: Vice President and Chief
Financial Officer (Principal
Financial and Accounting Officer)
Date: May 15, 2006
By: /s/ Raymund Breu
-----------------------------------------
Name: Raymund Breu
Title: Director
Date: May 15, 2006
By: /s/ Paulo Costa
-----------------------------------------
Name: Paulo Costa
Title: Director
Date: May 15, 2006